- A new trial is aiming to reduce symptoms and improve the quality of life of young Australians with hay fever, the country’s most common allergic disease
- 17 general practices and allergy clinics across Australia have partnered with the National Allergy Centre of Excellence (NACE), hosted at Murdoch Children’s Research Institute (MCRI), to launch the ARISE Trial
- The clinical trial is seeking 14 to 29 year olds with hay fever, with participants to follow a specifically designed education package alongside their daily nasal spray. The trial will explore whether they experience less symptoms and have better quality of life
- If successful, the trial will change the way hay fever is managed, reducing the burden on those living with the disease, their families and the healthcare system
- (03) 9305 5555
